MedPath

An observational study to assess degree of diabetes control in terms of glycated haemoglobin, proportion of patients having diabetic complications and future risk of heart disease in diabetic patients receiving antidiabetic medication.

Not Applicable
Completed
Conditions
Health Condition 1: null- Type 2 Diabetes Mellitus
Registration Number
CTRI/2018/03/012806
Lead Sponsor
Shraddha M Pore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
221
Inclusion Criteria

All adult patients (>= 18 years) having diagnosis of Type 2 diabetes mellitus presenting to Medicine OPD and giving informed consent to participate in the study would be included in the study.

Exclusion Criteria

Pregnant women and patients declining to give informed consent would be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Current glycemic status in terms of HbA1c concentration in patients of Type 2 diabetes mellitus (T2DM) receiving treatment at tertiary care government hospital.Timepoint: One year
Secondary Outcome Measures
NameTimeMethod
Burden of diabetes complications namely neuropathy, nephropathy, retinopathy, <br/ ><br>cardiovascular diseases and diabetic foot in these patients. <br/ ><br>Timepoint: One year;Risk factors namely age, gender, hypoglycemic treatment, duration of diabetes and self reported medication adherence associated with unsatisfactory glycemic control in these patients.Timepoint: One year;Ten year UK Prospective Diabetes Study (UKPDS) coronary heart disease risk in patients with no known heart diseaseTimepoint: One year
© Copyright 2025. All Rights Reserved by MedPath